BHC

5.64

1.99% 0.11

Dopo l'orario di chiusura: 5.63 -0.010 -0.18%

Bausch Health Companies Inc (BHC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché BHC Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$5.53

Aprire:

$5.55

Volume 24 ore:

1.25M

Relative Volume:

0.64

Capitalizzazione di mercato:

$2.11B

Reddito:

$10.53B

Utile/perdita netta:

$-1.23B

Rapporto P/E:

-1.7375

EPS:

-3.246

Flusso di cassa netto:

$949.99M

1 W Prestazione:

-0.53%

1M Prestazione:

+5.42%

6M Prestazione:

-16.81%

1 anno Prestazione:

+14.40%

Intervallo 1D:

$5.55

$5.73

Intervallo di 1 settimana:

$5.38

$6.29

Portata 52W:

$4.41

$8.685

Bausch Health Companies Inc Stock (BHC) Company Profile

Nome

Bausch Health Companies Inc

Settore

Healthcare (1106)

Industria

Drug Manufacturers - Specialty & Generic (84)

Telefono

514-744-6792

Indirizzo

2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC

Dipendente

20,300

Cinguettio

Prossima data di guadagno

2026-04-29

Ultimi documenti SEC

BHC's Discussions on Twitter

Compare BHC vs TAK, ZTS, TEVA, HLN, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BHC Bausch Health Companies Inc	5.64	2.07B	10.53B	-1.23B	949.99M	-3.246
TAK Takeda Pharmaceutical Co Adr	16.55	52.32B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	112.54	47.38B	9.47B	2.67B	2.28B	6.0218
TEVA Teva Pharmaceutical Industries Ltd Adr	35.86	41.16B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.17	41.02B	14.54B	2.22B	2.58B	0.4871
UTHR United Therapeutics Corp	572.20	24.67B	3.18B	1.33B	1.04B	27.90

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-09	Iniziato	Barclays	Equal Weight
2024-08-02	Downgrade	Piper Sandler	Neutral → Underweight
2024-07-10	Iniziato	Raymond James	Mkt Perform
2023-09-20	Aggiornamento	Jefferies	Hold → Buy
2023-06-16	Downgrade	TD Cowen	Outperform → Market Perform
2022-07-29	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2022-07-29	Downgrade	Truist	Buy → Hold
2022-07-28	Downgrade	JP Morgan	Overweight → Neutral
2022-06-13	Ripresa	JP Morgan	Overweight
2021-03-24	Downgrade	BofA Securities	Neutral → Underperform
2021-02-17	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2021-01-22	Downgrade	Piper Sandler	Overweight → Neutral
2020-09-17	Aggiornamento	BofA Securities	Underperform → Neutral
2020-08-24	Reiterato	H.C. Wainwright	Buy
2020-06-17	Reiterato	H.C. Wainwright	Buy
2020-04-24	Iniziato	Citigroup	Buy
2020-04-02	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-01-29	Downgrade	Wolfe Research	Outperform → Peer Perform
2020-01-22	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2019-12-12	Aggiornamento	JP Morgan	Neutral → Overweight
2019-12-02	Iniziato	Goldman	Neutral
2019-10-25	Iniziato	Cowen	Outperform
2019-09-12	Iniziato	Guggenheim	Buy
2019-08-15	Aggiornamento	TD Securities	Hold → Buy
2019-07-19	Iniziato	Wolfe Research	Outperform
2019-06-11	Ripresa	Barclays	Overweight
2019-05-13	Aggiornamento	JP Morgan	Underweight → Neutral
2019-03-20	Iniziato	SunTrust	Buy
2019-01-02	Aggiornamento	Piper Jaffray	Neutral → Overweight
2018-11-05	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2018-09-13	Aggiornamento	Piper Jaffray	Underweight → Neutral

Mostra tutto

Bausch Health Companies Inc Borsa (BHC) Ultime notizie

May 05, 2026

Bausch Health (BHC) Q1 2026 Earnings Transcript - AOL.com

May 05, 2026

Bausch Health Companies Inc. (NYSE:BHC) Q1 2026 Earnings Call Transcript - Insider Monkey

May 05, 2026

May 04, 2026

Bausch Health Companies Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:BHC) 2026-05-04 - Seeking Alpha

May 04, 2026

Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight - GlobeNewswire Inc.

May 04, 2026

May 03, 2026

MSN Money - MSN

May 03, 2026

May 02, 2026

Bausch Health rises on Q1 double beat, 2026 guidance - MSN

May 02, 2026

Bausch Health reaffirms 2026 guidance of $5.250B-$5.400B revenue and $2.875B-$2.950B adjusted EBITDA as tariffs are built in - MSN

May 02, 2026

Bausch Health Companies Q1 2026 Results: Revenue Up 12%, EPS Beats ForecastsNews and Statistics - IndexBox

May 02, 2026

May 01, 2026

Bausch Health Companies Inc. Q1 2026 Quarterly Report Highlights Financial Performance, Risks, and Forward-Looking Statements - Minichart

Apr 30, 2026

Bausch Health Cos (NYSE:BHC) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat

Apr 30, 2026

Bausch Health Rises on Strong 1Q Segment Growth, Revenue Beat - Moomoo

Apr 30, 2026

BHC Q1 Earnings Miss Estimates, Sales Grow on Salix & Solta Strength - The Globe and Mail

Apr 30, 2026

RBC Keeps Sector Perform Rating, US$9.00 Price Target, on Bausch Health After Strong Q1 - marketscreener.com

Apr 30, 2026

RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $9 - Moomoo

Apr 30, 2026

Apr 29, 2026

Bausch Health Cos Q1 Earnings Call Highlights - MarketBeat

Apr 29, 2026

Bausch Health (BHC) Lags Q1 Earnings Estimates - Yahoo Finance

Apr 29, 2026

Compared to Estimates, Bausch (BHC) Q1 Earnings: A Look at Key Metrics - Yahoo Finance

Apr 29, 2026